All In Biotech

Drug Trial Radar · NCT06100627

A Pharmacodynamic Effect Study of AP301 in Healthy Volunteers

A Randomized, Open-Label, Parallel Group, Phase 1 Study to Assess the Pharmacodynamic Effect of AP301 on Urinary Phosphorus Excretion in Healthy Volunteers

Last checked: Nov 19, 2026Latest source record: May 10, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

32

Actual

Start

Jan 11, 2024

Primary completion

Feb 8, 2024

Study completion Feb 28, 2024

Sponsor

Lead sponsor
Alebund Pty LtdIndustry
Sponsor type
Industry
First posted
Oct 25, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Male only, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a randomized, open-label, parallel-group, phase 1 study to evaluate the PD effect of AP301 capsule in healthy volunteers. The study is planned to have 4 treatment arms: Arm 1: 2.10 g/day; arm 2: 4.20 g/day; arm 3: 6.30 g/day; arm 4: 8.40 g/day.

Conditions

  • Healthy Subjects

Interventions

  • AP301Drug

    Orally administered

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Urinary phosphorus excretion during AP301 administrationTime frame: From the Day 1 to Day 4 after dosing, assessed up to 3 days
  2. Effect of AP301 on urinary phosphorus excretionTime frame: From Day -3 to Day 4 after dosing, assessed up to 6 days
  3. Urinary calcium excretion during AP301 administrationTime frame: From the Day 1 to Day 4 after dosing, assessed up to 3 days
  4. Effect of AP301 on urinary calcium excretionTime frame: From Day -3 to Day 4 after dosing, assessed up to 6 days
  5. Effect of AP301 on serum phosphorus and calciumTime frame: From Day -3 to Day 4 after dosing, assessed up to 6 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Nucleus Network Pty Ltd

    Melbourne, Victoria, Australia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.